C71T
CANCELLED SECTION 71
02/06/2026
Back to search
Official data from USPTO
SENTRAGOR ANTIBODY-ENHANCED DETECTION OF SENESCENT CELLS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/03/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
10/30/2018
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
SPARROW, MARY
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "SenTraGor", where "SenTra" is teal and "Gor" is purple. On the next line is the wording "Antibody-enhanced detection of Senescent cells" in black. To the left of the wording is a molecular design shaped like a laboratory flask containing lines and circles in the colors teal, purple and a central nucleus in grey.
Holders and representatives
Holders
T. M. (pessoa física)
AILERON PHARMACEUTICALS SA
Representatives
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific research use; reagents for the analysis of markings based on the fluorescence behavior of cells for scientific research purposes; reagents for medical research use; reagents for the analysis of markings based on the fluorescence behavior of cells for medical research purposes
Class 5
Chemical and/or biological preparations for medical usediagnostic preparations for medical and veterinary use; biological products for diagnosis and analysis for medical usediagnostic biomarker reagents for medical purposes; chemical preparations for medical and pharmaceutical usereagents for medical usechemical reagents for medical or veterinary use; medicines for human usemedicinal preparations for oral administration in the form of dropscapsulescompressed tablets and pills
Publications
History of USPTO decisions and trademark events.
30 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/29/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/29/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/29/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/29/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/29/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/29/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/29/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/11/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/30/2020
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/15/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
11/15/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
NPUB
NOTICE OF PUBLICATION
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2019
RFNT
REFUSAL PROCESSED BY IB
03/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/15/2019
RFRR
REFUSAL PROCESSED BY MPU
02/15/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/15/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/14/2019
CNRT
NON-FINAL ACTION WRITTEN
02/13/2019
DOCK
ASSIGNED TO EXAMINER
02/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/07/2019
Continuous trademark protection
Get notified about every new filing that threatens SENTRAGOR ANTIBODY-ENHANCED DETECTION OF SENESCENT CELLS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.